Zobrazeno 1 - 10
of 251
pro vyhledávání: '"János, Kappelmayer"'
Autor:
Renáta Sütő, Marianna Pócsi, Zsolt Szabó, Zsolt Fejes, Gergely Ivády, György Kerekes, Miklós Fagyas, Attila Nagy, Zoltán Szentkereszty, János Kappelmayer, Béla Nagy
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background We retrospectively analyzed serum level of human epididymis protein 4 (HE4) as a pulmonary inflammatory biomarker in patients with COVID-19 pneumonia in association with disease severity and outcome. Methods Ninety-nine (40 critic
Externí odkaz:
https://doaj.org/article/e43e120fd23049329ea3525d6e10d89c
Autor:
Bálint Krajcsir, Marianna Pócsi, Zsolt Fejes, Béla Nagy, János Kappelmayer, Ildikó Beke Debreceni
Publikováno v:
Pharmaceutics, Vol 16, Iss 4, p 559 (2024)
BCR-ABL tyrosine kinase inhibitors (TKIs) are effective drugs in the treatment of patients with chronic myeloid leukemia. However, based on clinical studies, ponatinib was associated with the development of thrombotic complications. Since endothelial
Externí odkaz:
https://doaj.org/article/108878418ffc48d4bbba4ccb620a4696
Autor:
Vivien Stercel, Linda Lóczi, Orsolya Kadenczki, Éva Nemes, Béla Nagy, Rebeka Hodossy-Takács, Attila Ádám Szabó, Miklós Fagyas, János Kappelmayer, Tamás Szabó, Zsuzsa Bagoly
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundInflammatory bowel disease (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC), are associated with higher thrombotic risk and enhanced thrombin generation (TG) in adults. Despite encouraging data reporting vaccine safety and
Externí odkaz:
https://doaj.org/article/228e02095c734a628af9877f254ff62c
Autor:
Dorottya Szántó, Péter Luterán, Nikolett Kóti, Péter Siró, Éva Simon, Zsuzsa Jakab, Judit Gál, János Kappelmayer, Béla Fülesdi, Csilla Molnár
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 7, p 1955 (2024)
Background: The present work aimed to determine whether a relationship exists between inflammatory parameters and the development of vasospasm (VS) and Takotsubo cardiomyopathy (TTC), as well as clinical outcome, in patients suffering from spontaneou
Externí odkaz:
https://doaj.org/article/c55f31b5a01441b391e252ceae6218e5
Autor:
Renáta Sütő, Marianna Pócsi, Miklós Fagyas, Edit Kalina, Zsolt Fejes, Zoltán Szentkereszty, János Kappelmayer, Béla Nagy Jr.
Publikováno v:
Microorganisms, Vol 12, Iss 1, p 229 (2024)
Severe SARS-CoV-2 elicits a hyper-inflammatory response that results in intravascular inflammation with endothelial injury, which contributes to increased mortality in COVID-19. To predict the outcome of severe SARS-CoV-2 infection, we analyzed the b
Externí odkaz:
https://doaj.org/article/8fdcb05175714121a420adf163769781
Autor:
Ádám Illési, Zsolt Fejes, Marianna Pócsi, Ildikó Beke Debreceni, Katalin Hodosi, Béla Nagy Jr., János Kappelmayer, Zsolt Kőszegi, Zoltán Csanádi, Tibor Szük
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 21, p 6829 (2023)
Percutaneous coronary intervention (PCI) is a frequently performed treatment option for recanalization in patients with chronic total occlusion (CTO). As CTO-PCIs are often complicated and challenging for interventionalists, the stressful and damagin
Externí odkaz:
https://doaj.org/article/4ce9d2bbc7754fcf95b694ec239fb17f
Autor:
Miklós Fagyas, Zsolt Fejes, Renáta Sütő, Zsuzsanna Nagy, Borbála Székely, Marianna Pócsi, Gergely Ivády, Edina Bíró, Gabriella Bekő, Attila Nagy, György Kerekes, Zoltán Szentkereszty, Zoltán Papp, Attila Tóth, János Kappelmayer, Béla Nagy, Jr.
Publikováno v:
International Journal of Infectious Diseases, Vol 115, Iss , Pp 8-16 (2022)
Objectives: Angiotensin-converting enzyme 2 (ACE2) represents the primary receptor for SARS-CoV-2 to enter endothelial cells. Here we investigated circulating ACE2 activity to predict the severity and mortality of COVID-19. Methods: Serum ACE2 activi
Externí odkaz:
https://doaj.org/article/e66c5aaf070048b0bb2bb110f12d9088
Autor:
Lilla Szuromi, Orsolya Hajas, Edina Nagy-Baló, Ildikó N. Forgács, László T. Nagy, Miklós Fagyas, Attila Tóth, Béla Nagy Jr, János Kappelmayer, Zoltán Csanádi
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 24, Iss 6, p 171 (2023)
Background: Atrial fibrillation (AF) is accompanied by inflammation and fibrosis to variable extent. The biomarkers of fibrosis were measured in patients with different forms of AF and cardiac status. Herein, we assessed the associations of the basel
Externí odkaz:
https://doaj.org/article/260193083361440d87283254de28529d
Autor:
Eszter Csoma, Ágnes Nagy Koroknai, Renáta Sütő, Erika Szakács Szilágyi, Marianna Pócsi, Attila Nagy, Klára Bíró, János Kappelmayer, Béla Nagy
Publikováno v:
Microorganisms, Vol 11, Iss 5, p 1187 (2023)
Background: Limited data are available on humoral responses determined by automated neutralization tests following the administration of the three different types of COVID-19 vaccinations. Thus, we here evaluated anti-SARS-CoV-2 neutralizing antibody
Externí odkaz:
https://doaj.org/article/0d1a1aabd8064aa5b62995966223f0b1
Autor:
Csilla Molnár, Judit Gál, Dorottya Szántó, László Fülöp, Andrea Szegedi, Péter Siró, Endre V Nagy, Szabolcs Lengyel, János Kappelmayer, Béla Fülesdi
Publikováno v:
PLoS ONE, Vol 17, Iss 5, p e0268525 (2022)
BackgroundTakotsubo cardiomyopathy (TTC) is an important complication of subarachnoid hemorrhage (SAH), that may delay surgical or endovascular treatment and may influence patient outcome. This prospective follow-up study intended to collect data on
Externí odkaz:
https://doaj.org/article/843d8fc1d77b47fe9105b468ea272c11